PMC:7289100 / 41292-42777
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T126 | 40-48 | Body_part | denotes | cytokine | http://purl.org/sig/ont/fma/fma84050 |
T127 | 74-78 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
T128 | 96-107 | Body_part | denotes | lymphocytes | http://purl.org/sig/ont/fma/fma62863 |
T129 | 109-118 | Body_part | denotes | monocytes | http://purl.org/sig/ont/fma/fma62864 |
T130 | 124-135 | Body_part | denotes | fibroblasts | http://purl.org/sig/ont/fma/fma63877 |
T131 | 230-246 | Body_part | denotes | epithelial cells | http://purl.org/sig/ont/fma/fma66768 |
T132 | 241-246 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T133 | 494-502 | Body_part | denotes | cytokine | http://purl.org/sig/ont/fma/fma84050 |
T134 | 537-542 | Body_part | denotes | blood | http://purl.org/sig/ont/fma/fma9670 |
T135 | 570-577 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T136 | 1088-1093 | Body_part | denotes | lungs | http://purl.org/sig/ont/fma/fma68877 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T54 | 537-542 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T492 | 137-146 | Disease | denotes | Infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T493 | 162-170 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T494 | 162-166 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T495 | 370-378 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T496 | 370-374 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T497 | 381-390 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T498 | 392-400 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T499 | 421-433 | Disease | denotes | inflammation | http://purl.obolibrary.org/obo/MONDO_0021166 |
T500 | 446-465 | Disease | denotes | respiratory failure | http://purl.obolibrary.org/obo/MONDO_0021113 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T306 | 8-9 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T307 | 61-62 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T308 | 74-84 | http://purl.obolibrary.org/obo/CL_0000000 | denotes | cell types |
T309 | 109-118 | http://purl.obolibrary.org/obo/CL_0000576 | denotes | monocytes |
T310 | 124-135 | http://purl.obolibrary.org/obo/CL_0000057 | denotes | fibroblasts |
T311 | 179-180 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T312 | 230-240 | http://purl.obolibrary.org/obo/CL_0000066 | denotes | epithelial |
T313 | 241-246 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T314 | 537-542 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
T315 | 537-542 | http://www.ebi.ac.uk/efo/EFO_0000296 | denotes | blood |
T316 | 609-612 | http://purl.obolibrary.org/obo/CLO_0053001 | denotes | 114 |
T317 | 623-626 | http://purl.obolibrary.org/obo/CLO_0001046 | denotes | 116 |
T318 | 744-745 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T319 | 1046-1047 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T320 | 1088-1093 | http://www.ebi.ac.uk/efo/EFO_0000934 | denotes | lungs |
T321 | 1106-1107 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T322 | 1295-1296 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T168 | 0-2 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
T170 | 210-212 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
T172 | 262-264 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
T174 | 553-555 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
T176 | 570-577 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T177 | 691-693 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
T179 | 812-823 | Chemical | denotes | tocilizumab | http://purl.obolibrary.org/obo/CHEBI_64360 |
T180 | 955-966 | Chemical | denotes | tocilizumab | http://purl.obolibrary.org/obo/CHEBI_64360 |
T181 | 1008-1014 | Chemical | denotes | oxygen | http://purl.obolibrary.org/obo/CHEBI_25805 |
T182 | 1255-1266 | Chemical | denotes | tocilizumab | http://purl.obolibrary.org/obo/CHEBI_64360 |
T183 | 1404-1415 | Chemical | denotes | tocilizumab | http://purl.obolibrary.org/obo/CHEBI_64360 |
T184 | 1445-1455 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T211 | 446-465 | Phenotype | denotes | respiratory failure | http://purl.obolibrary.org/obo/HP_0002878 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T19 | 324-346 | http://purl.obolibrary.org/obo/GO_0006954 | denotes | inflammatory responses |
T20 | 421-433 | http://purl.obolibrary.org/obo/GO_0006954 | denotes | inflammation |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T252 | 0-136 | Sentence | denotes | IL-6 is a pleiotropic, pro-inflammatory cytokine produced by a variety of cell types, including lymphocytes, monocytes, and fibroblasts. |
T253 | 137-247 | Sentence | denotes | Infection by the related SARS-CoV induces a dose-dependent production of IL-6 from bronchial epithelial cells. |
T254 | 248-391 | Sentence | denotes | Elevations in IL-6 levels may be an important mediator when severe systemic inflammatory responses occur in patients with SARS-CoV-2 infection. |
T255 | 392-629 | Sentence | denotes | COVID-19-associated systemic inflammation and hypoxic respiratory failure is associated with an acute cytokine release, as indicated by elevated blood levels of IL-6, C-reactive protein (CRP), D-dimer, and ferritin [[114], [115], [116]]. |
T256 | 630-740 | Sentence | denotes | Few clinical studies aiming to evaluate the efficacy of anti-IL-6 receptor blocker have been published so far. |
T257 | 741-934 | Sentence | denotes | In a report from China by Xu et al. the authors were able to show that tocilizumab effectively improved clinical symptoms as well as reversed the deterioration of sever Covid-19 patients [117]. |
T258 | 935-1185 | Sentence | denotes | Within 5 days after tocilizumab, 15 of the 20 patients had lowered their oxygen intake and 19 of the 20 showed a noticeable improvement in the CT of the lungs, as well as a significant reduction in CRP levels which was noted in 16 of the 19 patients. |
T259 | 1186-1274 | Sentence | denotes | All patients have been discharged on an average of 15 days after the tocilizumab dosing. |
T260 | 1275-1361 | Sentence | denotes | Even though this is a small and uncontrolled study, the results seem to be impressive. |
T261 | 1362-1485 | Sentence | denotes | Over 20 randomized controlled trials with tocilizumab, or sarilumab as well as JAK-inhibitors as baricitinib, are underway. |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T557 | 0-4 | PR:000001393 | denotes | IL-6 |
T558 | 96-107 | CL:0000542 | denotes | lymphocytes |
T559 | 109-118 | CL:0000576 | denotes | monocytes |
T560 | 124-135 | CL:0000057 | denotes | fibroblasts |
T561 | 162-170 | SP_10 | denotes | SARS-CoV |
T562 | 210-214 | PR:000001393 | denotes | IL-6 |
T563 | 220-240 | UBERON:0002031;CL:0002328 | denotes | bronchial epithelial |
T564 | 241-246 | CL:0002328 | denotes | cells |
T565 | 262-266 | PR:000001393 | denotes | IL-6 |
T566 | 370-380 | SP_7 | denotes | SARS-CoV-2 |
T567 | 392-400 | SP_7 | denotes | COVID-19 |
T568 | 446-457 | UBERON:0001004 | denotes | respiratory |
T569 | 537-542 | UBERON:0000178 | denotes | blood |
T570 | 553-557 | PR:000001393 | denotes | IL-6 |
T571 | 559-577 | PR:000005897 | denotes | C-reactive protein |
T572 | 579-582 | PR:000005897 | denotes | CRP |
T573 | 691-695 | PR:000001393 | denotes | IL-6 |
T574 | 812-823 | DG_35 | denotes | tocilizumab |
T575 | 910-918 | SP_7 | denotes | Covid-19 |
T576 | 955-966 | DG_35 | denotes | tocilizumab |
T577 | 1088-1093 | UBERON:0000170 | denotes | lungs |
T578 | 1255-1266 | DG_35 | denotes | tocilizumab |
T579 | 1404-1415 | DG_35 | denotes | tocilizumab |
T580 | 1420-1429 | DG_39 | denotes | sarilumab |
T581 | 1445-1455 | CHEBI:35222;CHEBI:35222 | denotes | inhibitors |
T582 | 1459-1470 | DG_41 | denotes | baricitinib |
T21859 | 0-4 | PR:000001393 | denotes | IL-6 |
T19136 | 96-107 | CL:0000542 | denotes | lymphocytes |
T28167 | 109-118 | CL:0000576 | denotes | monocytes |
T98906 | 124-135 | CL:0000057 | denotes | fibroblasts |
T25741 | 162-170 | SP_10 | denotes | SARS-CoV |
T11441 | 210-214 | PR:000001393 | denotes | IL-6 |
T67653 | 220-240 | UBERON:0002031;CL:0002328 | denotes | bronchial epithelial |
T73773 | 241-246 | CL:0002328 | denotes | cells |
T15981 | 262-266 | PR:000001393 | denotes | IL-6 |
T39306 | 370-380 | SP_7 | denotes | SARS-CoV-2 |
T89461 | 392-400 | SP_7 | denotes | COVID-19 |
T69527 | 446-457 | UBERON:0001004 | denotes | respiratory |
T63239 | 537-542 | UBERON:0000178 | denotes | blood |
T30193 | 553-557 | PR:000001393 | denotes | IL-6 |
T46291 | 559-577 | PR:000005897 | denotes | C-reactive protein |
T28455 | 579-582 | PR:000005897 | denotes | CRP |
T70338 | 691-695 | PR:000001393 | denotes | IL-6 |
T60533 | 812-823 | DG_35 | denotes | tocilizumab |
T64207 | 910-918 | SP_7 | denotes | Covid-19 |
T25449 | 955-966 | DG_35 | denotes | tocilizumab |
T54606 | 1088-1093 | UBERON:0000170 | denotes | lungs |
T83703 | 1255-1266 | DG_35 | denotes | tocilizumab |
T67676 | 1404-1415 | DG_35 | denotes | tocilizumab |
T51113 | 1420-1429 | DG_39 | denotes | sarilumab |
T28736 | 1445-1455 | CHEBI:35222;CHEBI:35222 | denotes | inhibitors |
T15613 | 1459-1470 | DG_41 | denotes | baricitinib |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1408 | 0-4 | Gene | denotes | IL-6 | Gene:3569 |
1409 | 210-214 | Gene | denotes | IL-6 | Gene:3569 |
1410 | 262-266 | Gene | denotes | IL-6 | Gene:3569 |
1411 | 553-557 | Gene | denotes | IL-6 | Gene:3569 |
1412 | 559-577 | Gene | denotes | C-reactive protein | Gene:1401 |
1413 | 579-582 | Gene | denotes | CRP | Gene:1401 |
1414 | 1133-1136 | Gene | denotes | CRP | Gene:1401 |
1415 | 162-170 | Species | denotes | SARS-CoV | Tax:694009 |
1416 | 356-364 | Species | denotes | patients | Tax:9606 |
1417 | 919-927 | Species | denotes | patients | Tax:9606 |
1418 | 981-989 | Species | denotes | patients | Tax:9606 |
1419 | 1176-1184 | Species | denotes | patients | Tax:9606 |
1420 | 1190-1198 | Species | denotes | patients | Tax:9606 |
1421 | 812-823 | Chemical | denotes | tocilizumab | MESH:C502936 |
1422 | 955-966 | Chemical | denotes | tocilizumab | MESH:C502936 |
1423 | 1008-1014 | Chemical | denotes | oxygen | MESH:D010100 |
1424 | 1255-1266 | Chemical | denotes | tocilizumab | MESH:C502936 |
1425 | 1404-1415 | Chemical | denotes | tocilizumab | MESH:C502936 |
1426 | 1420-1429 | Chemical | denotes | sarilumab | MESH:C000592401 |
1427 | 1459-1470 | Chemical | denotes | baricitinib | MESH:C000596027 |
1428 | 137-146 | Disease | denotes | Infection | MESH:D007239 |
1429 | 370-390 | Disease | denotes | SARS-CoV-2 infection | MESH:C000657245 |
1430 | 392-400 | Disease | denotes | COVID-19 | MESH:C000657245 |
1431 | 421-433 | Disease | denotes | inflammation | MESH:D007249 |
1432 | 438-465 | Disease | denotes | hypoxic respiratory failure | MESH:D012131 |
1433 | 910-918 | Disease | denotes | Covid-19 | MESH:C000657245 |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32535093-32171076-4828887 | 609-612 | 32171076 | denotes | 114 |
32535093-31986264-4828888 | 616-619 | 31986264 | denotes | 115 |